Insider Selling: Healthequity Inc (HQY) VP Sells 4,000 Shares of Stock

Healthequity Inc (NASDAQ:HQY) VP Darcy G. Mott sold 4,000 shares of Healthequity stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $84.60, for a total value of $338,400.00. Following the transaction, the vice president now owns 70,000 shares of the company’s stock, valued at approximately $5,922,000. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Healthequity stock traded up $1.35 during trading on Monday, hitting $75.09. The stock had a trading volume of 441,100 shares, compared to its average volume of 829,935. Healthequity Inc has a 1 year low of $50.29 and a 1 year high of $101.58. The company has a market cap of $4.61 billion, a price-to-earnings ratio of 79.04, a PEG ratio of 3.24 and a beta of 1.70.

Healthequity (NASDAQ:HQY) last posted its quarterly earnings data on Monday, March 18th. The company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.15 by $0.06. Healthequity had a return on equity of 13.59% and a net margin of 25.73%. The business had revenue of $75.78 million for the quarter, compared to the consensus estimate of $74.28 million. During the same quarter in the prior year, the business earned $0.09 earnings per share. Healthequity’s revenue for the quarter was up 25.4% on a year-over-year basis. Equities analysts anticipate that Healthequity Inc will post 0.94 earnings per share for the current year.

A number of equities analysts have issued reports on the company. BidaskClub upgraded Healthequity from a “buy” rating to a “strong-buy” rating in a research note on Friday, April 5th. Oppenheimer lifted their price target on Healthequity from $74.00 to $98.00 and gave the company an “outperform” rating in a research note on Tuesday, March 19th. Bank of America boosted their target price on Healthequity from $82.00 to $83.00 and gave the stock a “neutral” rating in a research note on Tuesday, March 19th. KeyCorp boosted their target price on Healthequity from $74.00 to $90.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 19th. Finally, Cantor Fitzgerald boosted their target price on Healthequity from $83.00 to $90.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 19th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $86.85.

A number of hedge funds have recently modified their holdings of HQY. Morgan Stanley raised its holdings in Healthequity by 15.5% during the 3rd quarter. Morgan Stanley now owns 4,001,425 shares of the company’s stock valued at $377,775,000 after acquiring an additional 536,366 shares during the period. Norges Bank bought a new stake in Healthequity during the 4th quarter valued at $29,950,000. Clearbridge Investments LLC raised its holdings in Healthequity by 976,643.6% during the 3rd quarter. Clearbridge Investments LLC now owns 380,930 shares of the company’s stock valued at $35,964,000 after acquiring an additional 380,891 shares during the period. Massachusetts Financial Services Co. MA bought a new stake in Healthequity during the 4th quarter valued at $15,455,000. Finally, Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Healthequity in the third quarter worth $19,021,000. 96.13% of the stock is currently owned by institutional investors and hedge funds.

WARNING: This story was originally posted by Baseball Daily News and is the property of of Baseball Daily News. If you are reading this story on another site, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://www.baseballdailydigest.com/news/2019/04/15/darcy-g-mott-sells-4000-shares-of-healthequity-inc-hqy-stock.html.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Story: Why is insider trading harmful?

Insider Buying and Selling by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.